Simiao Lin

1.1k total citations
9 papers, 465 citations indexed

About

Simiao Lin is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Simiao Lin has authored 9 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Simiao Lin's work include CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (4 papers) and Immune Cell Function and Interaction (4 papers). Simiao Lin is often cited by papers focused on CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (4 papers) and Immune Cell Function and Interaction (4 papers). Simiao Lin collaborates with scholars based in China, United Kingdom and Taiwan. Simiao Lin's co-authors include Peng Li, Qiting Wu, Yao Yao, Xinru Wei, Baiheng Li, Pentao Liu, Duanqing Pei, Yunxin Lai, Suna Wang and Xin Du and has published in prestigious journals such as Journal of Hazardous Materials, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Simiao Lin

9 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simiao Lin China 8 364 208 119 115 87 9 465
Tomasz Zabinski United Kingdom 6 279 0.8× 166 0.8× 84 0.7× 101 0.9× 84 1.0× 9 377
Su Jingwen China 6 353 1.0× 230 1.1× 109 0.9× 107 0.9× 70 0.8× 7 430
Guoxiu Du China 6 397 1.1× 233 1.1× 131 1.1× 84 0.7× 72 0.8× 6 516
Qiting Wu China 13 573 1.6× 323 1.6× 203 1.7× 173 1.5× 141 1.6× 26 745
Daijing Yuan China 7 314 0.9× 149 0.7× 114 1.0× 78 0.7× 39 0.4× 10 402
Robin Davies United States 4 519 1.4× 214 1.0× 103 0.9× 192 1.7× 145 1.7× 8 570
Kesang Li China 13 364 1.0× 270 1.3× 428 3.6× 83 0.7× 48 0.6× 20 811
Jiage Ding China 11 300 0.8× 227 1.1× 128 1.1× 60 0.5× 44 0.5× 18 414
Donghua Shi China 5 254 0.7× 158 0.8× 68 0.6× 55 0.5× 42 0.5× 7 353
Mengmeng Lü China 11 328 0.9× 207 1.0× 115 1.0× 87 0.8× 53 0.6× 15 447

Countries citing papers authored by Simiao Lin

Since Specialization
Citations

This map shows the geographic impact of Simiao Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simiao Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simiao Lin more than expected).

Fields of papers citing papers by Simiao Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simiao Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simiao Lin. The network helps show where Simiao Lin may publish in the future.

Co-authorship network of co-authors of Simiao Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Simiao Lin. A scholar is included among the top collaborators of Simiao Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simiao Lin. Simiao Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lin, Simiao, et al.. (2025). Why Do Tourists Visit the Food Market? A Host–Guest Sharing Model Based on the Theory of Self-Regulation. Land. 14(2). 407–407. 1 indexed citations
2.
Lin, Shouheng, Lin Cheng, Wei Ye, et al.. (2021). Chimeric CTLA4-CD28-CD3z T Cells Potentiate Antitumor Activity Against CD80/CD86–Positive B Cell Malignancies. Frontiers in Immunology. 12. 642528–642528. 19 indexed citations
3.
Wu, Di, Jiang Lv, Ruocong Zhao, et al.. (2020). PSCA is a target of chimeric antigen receptor T cells in gastric cancer. Biomarker Research. 8(1). 3–3. 34 indexed citations
4.
Zhao, Ruocong, Lin Cheng, Zhiwu Jiang, et al.. (2018). DNAX-activating protein 10 co-stimulation enhances the anti-tumor efficacy of chimeric antigen receptor T cells. OncoImmunology. 8(1). e1509173–e1509173. 26 indexed citations
5.
Wei, Xinru, Yunxin Lai, Jin Li, et al.. (2017). PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells. OncoImmunology. 6(3). e1284722–e1284722. 106 indexed citations
6.
Wei, Xinru, Yunxin Lai, Baiheng Li, et al.. (2017). CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg−/− Mice Results in Severe Immunodeficiency. Scientific Reports. 7(1). 7720–7720. 8 indexed citations
7.
Qin, Le, Yunxin Lai, Ruocong Zhao, et al.. (2017). Incorporation of a hinge domain improves the expansion of chimeric antigen receptor T cells. Journal of Hematology & Oncology. 10(1). 68–68. 79 indexed citations
8.
Jiang, Zhiwu, Xiaofeng Jiang, Yunxin Lai, et al.. (2017). Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma. Frontiers in Immunology. 7. 690–690. 181 indexed citations
9.
Lin, Simiao, et al.. (2008). Calorimetric evaluation of polymerization thermokinetics of styrene, α-methylstyrene and trans-β-methylstyrene. Journal of Hazardous Materials. 161(1). 330–335. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026